Forkhead O transcription factors (FOXOs) have been implicated in glucose and lipid homeostasis; however, the role of FOXOs in the development of nonalcoholic fatty liver disease (NAFLD) is not well understood. In this study, we designed experiments to examine the effects of two different diets-very high fat diet (HFD) and moderately high fat plus cholesterol diet (HFC)-on wildtype (WT) and liverspecific Foxo1/3/4 triple knockout mice (LTKO). Both diets induced severe hepatic steatosis in the LTKO mice as compared to WT controls. However, the HFC diet led to more severe liver injury and fibrosis compared to the HFD diet. At the molecular levels, hepatic Foxo1/3/4 deficiency triggered a significant increase in the expression of inflammatory and fibrotic genes including Emr1, Ccl2, Col1a1, Tgfb, Pdgfrb, and Timp1. Thus, our data suggest that FOXO transcription factors play a salutary role in the protection against the diet-induced fatty liver disease.
Forkhead O transcription factors (FOXOs) play a critical role in the integration of hormonal and nutritional signals for metabolic control 1 . As a downstream mediator of insulin signaling, the activity of FOXOs is modulated by serine/threonine phosphorylation catalyzed by Akt and other kinases. This insulin-mediated regulation has been implicated in the metabolic control during fasting and feeding cycles. In general, during feeding FOXOs are largely inhibited by the insulin-stimulated Akt whereas during fasting FOXOs are less phosphorylated and actively promote gluconeogenesis and lipolysis and inhibit glycolysis and lipogenesis [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . With regard to hepatic lipid metabolism, FOXOs play a key role in integrating multiple pathways. FOXOs have been shown to inhibit lipogenesis through suppression of genes such as sterol regulatory element binding protein 1c (SREBP-1c) and glucokinase 6, [14] [15] [16] [17] [18] [19] . FOXOs also interplay with sirtuin proteins, especially SIRT1 and SIRT6 6, 7, [20] [21] [22] [23] [24] [25] . As sirtuins are NAD-dependent enzymes, FOXOs have been shown to modulate sirtuin activities through control of expression of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in the NAD biosynthesis 8 . Both SIRT1 and SIRT6 have been shown to inhibit lipogenesis and promote fatty acid oxidation in the liver 24 . FOXOs also promote hepatic lipolysis by upregulation of adipose triglyceride lipase (ATGL) that catalyzes the first step of lipolysis and downregulation of the G0/S1 switch 2 gene (G0S2), an inhibitor of ATGL 4 . In addition, FOXOs also increase breakdown of lipid droplets through activation of the autophagy pathway as autophagy related 14 (ATG14) has been shown to be a direct target of FOXOs 26 . Both endogenous and exogenous factors can cause dysregulation of hepatic lipid homeostasis. One of the critical environmental factors is diet. It has been shown that diets containing excessive amount of fat, especially saturated fatty acids, remarkably increase the risk of obesity and nonalcoholic fatty liver disease (NAFLD) [27] [28] [29] [30] . Additionally, dietary cholesterol has been attributed to the development of NAFLD 27, [31] [32] [33] [34] [35] [36] . We have recently reported that FOXOs regulate both total cholesterol and low-density lipoprotein cholesterol 7, 25 . Generally, NAFLD is a progressive liver disease, beginning with simple steatosis, progressing to nonalcoholic steatohepatitis (NASH) and fibrosis, and in some cases ending up as cirrhosis and hepatocellular carcinoma 37 . Understanding the mechanism and pathogenesis leading to hepatic steatosis or NASH is of importance, as early interventions will likely either delay or reverse the disease progression.
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To better understand the gene (notably FOXOs)-environment (different types of diets) interaction in the development of NAFLD, we set out to characterize wildtype (WT) and Foxo1/3/4 liver-specific triple knockout mice (LTKO) that were fed either regular chow, simply high-fat or moderately high-fat plus cholesterol diet.
Results
Dietary effects on food intake, body weight, liver, and adipose depot. Foxo1/3/4 gene knockout in the liver was confirmed by real-time PCR and immunoblotting ( Fig. 1A-D) . It was also noteworthy that both Foxo1 and Foxo3 genes were downregulated at both mRNA and protein levels in the liver of WT mice fed the HFC diet. Food intake measured by kcal/day was not significantly different among different dietary groups, but the HFD group gained more weight compared to the chow and HFC groups ( Fig. 2A and B) . The ratio of liver to body weight was increased nearly 2-fold in the LTKO mice as compared to the WT mice under the HFC dietary condition (p = 0.00045, Fig. 2C ). Although there is a trend of increase in the HFD group, the ratio of perigonadal fat pad to body weight was not statistically different among three dietary groups (Fig. 2D ).
Diet and gene effects on serum triglyceride, cholesterol, and alanine aminotransferase (ALT). Serum triglyceride (TG) levels were significantly higher in the LTKO mice compared to the WT mice among all three dietary groups (p = 0.018, p = 0.022, and p = 0.023, respectively), but there was no significant effect by diet within the same genotype (Fig. 3A) . Serum cholesterol levels were also elevated in the LTKO mice relative to the WT mice for the chow and HFC groups (p = 0.045 and p = 0.009, respectively, Fig. 3B ). Serum ALT is often used a marker for liver injury. Interestingly, serum ALT levels were significantly affected by both Foxo1/3/4 deficiency and diets (p = 0.003, p = 0.012, and p = 0.003 for LTKO vs. WT in chow, HFD, and HFC, respectively; p = 0.05, p < 0.0001, and p = 0.012 for LTKO mice chow vs. HFD, chow vs. HFC, and HFD vs. HFC, respectively). The LTKO mice fed with the HFC diet had the highest level of serum ALT, followed by those fed with the HFD and chow diets (Fig. 3C ).
Effects on hepatic steatosis and fibrosis. Liver sections were stained by hematoxylin and eosin for histological analysis. As shown in Fig. 4A , LTKO livers had increased lipid droplet accumulation in all three dietary conditions. However, liver tissues from mice fed with the HFC diet showed the worst hepatic steatosis with numerous large lipid droplets. Biochemical analysis of hepatic triglyceride contents also confirmed the steatosis phenotype in the LTKO mice under either HFD or HFC diet (Fig. 4B ). Histological analysis also revealed increased hepatic steatosis and inflammation in the LTKO mice using the numerical scoring systems (Fig. 4C and D) . Sirius Red stain was used to examine the presence of liver fibrosis. As shown in Fig. 5 , fibrosis was increased in both HFD and HFC groups compared to the chow group. Foxo1/3/4 deficiency further exacerbated the extent Effects on hepatic gene expression. To assess the molecular changes that lead to the phenotypic differences among the three dietary groups, we performed real-time PCR and Western blot analyses to determine differential expression of genes known to be involved in lipid metabolism and fibrogenesis. First, we examined the lipogenic genes including a key regulator Srebp1c and acetyl-CoA carboxylase 1 (Acc1). Although Srebp1c mRNA levels were increased in the liver of the HFC-treated mice, but they did not reach a statistical significance as compared to those fed with chow and HFD (Fig. 6A ). Second, we analyzed genes that are involved in fatty acid oxidation -carnitine palmitoyltransferase 1a (Cpt1a) and acyl-CoA oxidase 2 (Acox2). Expression of Cpt1a was significantly decreased in the liver of the HFC-treated mice whereas Acox2 mRNA levels were decreased in the liver of the HFD-treated mice as compared to the Chow-WT mice ( Fig. 6C and D) . Third, as inflammation is a critical factor in the progression of fatty liver disease from simple steatosis to NASH, we also analyzed two inflammatory marker genes -adhesion G protein-coupled receptor E1 (Adgre1, also named Emr1 or F4/80) and chemokine (C-C motif) ligand 2 (Ccl2, also named MCP-1). Expression of the Emr1 gene in the WT livers was induced by either HFD or HFC diet whereas it was further elevated in the HFC-treated LTKO mouse livers (Fig. 7A ). The hepatic Ccl2 mRNA levels were elevated in the LTKO mice compared to the WT mice under the chow diet condition but they did not reach a statistical significance. Fourth, we analyzed a few genes that are involved in the pathogenesis of hepatic fibrosis. Expression of platelet derived growth factor receptor, beta polypeptide (Pdgfrb) was elevated in the LTKO livers and further induced by the HFC diet (Fig. 7C) . The HFC diet also significantly induced expression of the transforming growth factor beta gene (Tgfb) in both WT and LTKO livers (Fig. 7D) . Hepatic expression of the type 1, alpha 1 collagen gene (Col1a1) was induced by either HFD or HFC, and Foxo1/3/4 deficiency further enhanced the Col1a1 gene expression (Fig. 7E) . Like the Col1a1 gene, expression of the tissue inhibitor of metalloproteinase 1 gene (Timp1) was also induced by HFD or HFC and the Foxo1/3/4 gene knockout (Fig. 7F) . The upregulation of the Pdgfrb and Tgfb genes was also confirmed at the protein levels (Fig. 7G) .
Hepatic neutrophil infiltration is one of the hallmark features in NASH. We performed immunohistochemistry (IHC) analysis of liver sections using a common neutrophil marker -myeloperoxidase (MPO). Both HFD and HFC increased the neutrophil infiltration in WT and LTKO mouse livers, but the LTKO mice exhibited more severe inflammation evidenced by the increased MPO staining intensity ( Fig. 8A and B) . Since NASH also manifests hepatic fibrosis, we also analyzed two fibrosis markers -alpha-smooth muscle actin (α -SMA) and TIMP1, in liver sections. In comparison to WT mice, LTKO mice on both HFD and HFC diets showed more pronounced fibrosis demonstrated by the elevated α -SMA and TIMP1 staining intensity (Fig. 9A-D) .
Discussion
In this work, we have demonstrated two critical factors that significantly contribute to the pathogenesis of NAFLD. The first factor is intrinsic -the function of FOXO transcription factors. FOXOs, especially FOXO3, have implicated in animal longevity and metabolic homeostasis 38 . Our data from the Foxo1/3/4-LTKO mice indicate that deletion of FOXO1/3/4 genes exacerbates diet-induced hepatic steatosis and liver injury, suggesting a protective role of FOXOs in the liver. The second factor is extrinsic or environmental -the diet composition. Not simply high content of saturated fat but moderately high content of fat plus cholesterol poses a higher risk for NAFLD.
From the biological functions of FOXOs, we are not surprised to see that FOXOs have protective effects on the development of NAFLD. There are several factors that contribute to the pathogenesis of steatosis: increased lipogenesis, increased uptake of free fatty acids, or decreased triglyceride breakdown or secretion in a form of VLDL 39 . Data from our laboratory and others have shown that FOXOs play a critical role in hepatic lipid homeostasis by inhibiting lipogenesis and increasing triglyceride breakdown [3] [4] [5] 8, 14, 17, 19, 26, 40 . In this work, we have observed that the expression of lipogenic and fatty acid oxidation genes is modulated by both FOXOs and diets. For example, the Cpt1a gene is significantly downregulated in HFC-treated LTKO livers whereas the Acox2 gene was decreased in the HFD-treated LTKO livers. In addition, FOXO1 and FOXO6 have been shown to promote VLDL production in the liver by activating the expression of the microsomal triglyceride transfer protein 41, 42 . Whether VLDL production is altered in the LTKO liver requires further investigation.
In recent years, cholesterol has been increasingly appreciated as a significant risk factor for NAFLD. A retrospective epidemiological study reveals that the ratio of total cholesterol to HDL-cholesterol is a significant risk factor for advanced NAFLD 31 . The association of cholesterol with NAFLD has also been reported in other studies 33, [43] [44] [45] . In one study, C57BL/6 J mice fed with 45% fat (by calorie) plus 0.2% cholesterol diet for 4 months manifest phenotypic features of NASH and fibrosis 46 . In another study, Sprague-Dawley rats were fed either a high-fat diet (30% palm oil), high-fat (28.75% palm oil) plus 1.25% cholesterol diet, or high-fat (27.5% palm oil) plus 2.5% cholesterol diet for 9 weeks 34 . The results are very similar to our data that the cholesterol-containing diets remarkably promote progression from simple steatosis to NASH. More significantly, the 2.5% cholesterol-containing diet induces liver cirrhosis in 40% of rats 34 . However, the underlying mechanisms on high cholesterol diet causing NASH are not well understood. Excess hepatic free cholesterol is believed to have adverse effects on hepatocytes, Kupffer cells and hepatic stellate cells, including alteration of cell membrane fluidity and membrane protein function, endoplasmic reticulum stress, mitochondrial dysfunction, and activation of Kupffer and stellate cells 32, [47] [48] [49] [50] [51] . Knockout of Foxo1/3 or Foxo1/3/4 in the mouse liver leads to elevated hepatic free cholesterol levels 7, 40 , suggesting that FOXOs play a critical role in hepatic cholesterol homeostasis. As demonstrated in this work, deletion of hepatic Foxo1/3/4 markedly aggravates the NAFLD phenotype by increasing hepatic inflammation and fibrosis, especially on the HFC diet.
Although we have attempted to address both gene and dietary effects on the development of NAFLD, the diet-gene interplay is much more complicated than what we have presented here. First of all, diets have global effects on the animal system, including key organs involved in the metabolic homeostasis like brain, pancreas, intestine, muscle, and adipose tissue 52, 53 . Second, both central and peripheral organs can impact liver physiology through inter-organ crosstalks 53 . For instance, white adipose tissue has strong interaction with hepatic lipid metabolism [53] [54] [55] . How those systemic and tissue-secreted factors may influence hepatic FOXO activity will be very interesting to be investigated in the future study.
In summary, our data reveals an important role of FOXO transcription factors in hepatic lipid homeostasis and their protection against the diet-induced fatty liver disease. These findings also suggest that the FOXO pathway may serve as a potential therapeutic target for NAFLD. 
Materials and Methods
Animals and diets. All animal care and experimental procedures performed in this study were approved by the Institutional Animal Care and Use Committee of Indiana University School of Medicine in accordance with National Institutes of Health guidelines for the care and use of laboratory animals. Foxo1/3/4 floxed (as WT control) and LTKO mice were generated as previously described 8 . Both males and females were used in the experiments. At 2-3 months of age, animals were fed either regular chow (Teklad Diets 2018SX: 24% calories from protein, 18% calories from fat, and 58% calories from carbohydrate), high-fat diet (HFD, Research Diets D12492: 20% calories from protein, 60% calories from fat, and 20% calories from carbohydrate), or moderately high-fat-cholesterol diet (HFC, Research Diets D12109C, 20% calories from protein, 40% calories from fat, 40% calories from carbohydrate, and 1.25% cholesterol by weight). The feeding experiment was conducted for 3 months. In the end, the animals were sacrificed for blood and tissue collection. As males and females had a similar phenotype, the data presented in this report were primarily collected from the male mice.
Blood chemistry and hepatic lipid analysis. Serum levels of cholesterol, triglycerides, and alanine aminotransferase were analyzed using commercial assay kits (Wako USA and Pointe Scientific, respectively) according to the manufacture's manuals. Hepatic triglycerides were extracted and analyzed as previously described 8 .
RNA isolation and real-time PCR analysis. Total RNAs from the liver tissues were isolated using TRI reagent (Sigma) as previously described 26 . cDNA was synthesized using a reverse transcription kit (Invitrogen). Real-time PCR analysis was performed using a SYBR Green PCR kit (Promega). Primer sequences are listed in the Supplementary Table 1 .
Protein analysis. Liver protein samples were prepared and analyzed as previously described 26 . The antibodies for the Foxo1, Foxo3, PDGF receptor β , and TGFβ proteins were purchased from Cell Signaling Technology (Beverly, MA), and the α -actinin and β -actin antibodies were purchased from Santa Cruz Biotechnology (Dallas, TX). The blots were scanned into digital files using a photo scanner (Epson V500).
Histology and IHC analysis. Liver tissue samples were fixed in 10% formalin and processed for embedding and sectioning at the Histology Core of Indiana University School of Medicine. Liver sections (5 μ m thickness) were stained with hematoxylin and eosin (H&E) or Sirius Red stain (Sigma). Immunohistochemistry analysis was performed for MPO, TIMP-1, and α -SMA. The liver tissue sections were deparaffinized, hydrated, and heated in 1 mM EDTA buffer for antigen retrieval at 100 °C for 5 min, and then treated with normal horse serum for 1 hour. Next, the slides were incubated with antibodies against MPO (1:100, Biocare Medical, Concord, CA), TIMP-1 (1:150, Proteintech, Rosemont, IL), or α -SMA (1:100, Cell Signaling Technology, Beverly, MA), for overnight. After washing with PBS buffer containing 0.05% Tween-20, the tissue sections were incubated with a biotinylated universal pan-specific antibody (PK-7200, Vectastain ABC kit, Vector Laboratories, Burlingame, CA) for 2 hours. The tissues were subsequently exposed to an avidin-biotin peroxidase complex (Vector Laboratories) for 1 hour. The peroxidase activity was visualized using a stable diaminobenzidine solution (Vector Laboratories). The images were captured using a regular microscope (200X magnification, Leica, Germany).
Quantitative scoring analysis of steatosis and inflammation in liver sections. The quantitative scoring of H&E-stain based liver tissue sections was conducted according to the previous methods with slight modifications, regarding steatosis 56, 57 and inflammation 58 , respectively. Briefly, each section was examined by a specialist who was blinded to the sample information and hepatic steatosis and inflammation scores were evaluated. The degree of steatosis was graded '0' to '4' based on the average percent of fat-accumulated hepatocyte per field at 200 × magnification under H&E staining (grading 0, < 5% of fat accumulation; grading 1, 5 to 25% of fat accumulation; grading 2, 26 to 50% of fat accumulation; grading 3, 51 to 75% of fat accumulation; grading 4, > 75% of fat accumulation). The histopathological alterations for inflammation were also scored on 200X magnification H&E stained liver sections (grading 0, from normal, absence of pathology to <5% of maximum pathology; grading 1, < 10% of maximum pathology: grading 2, 10% to 20% of maximum pathology; grading 3, > 20% of maximum pathology).
The intensity of MPO, α -SMA and TIMP-positive signals in IHC images was quantified from the randomly selected sections at least five fields of each sample using Image J 1.46 software (NIH, Bethesda, MD). The staining intensity was normalized to the Chow-WT group and was presented as fold change.
Statistical analysis. Data were presented as mean ± standard error (SEM). Comparisons between two groups were performed using two-tailed student t-test, and comparisons among multiple groups were analyzed using two-way ANOVA followed by Tukey post hoc test (GraphPad, La Jolla, CA). Differences with a p value < 0.05 were considered statistically significant. 
